1-15 of 15
Yuanfang Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of a Novel BCMA×CD3 Bispecific Antibody Emb-06 in Relapsed or Refractory Multiple Myeloma

Peter Tan, LI Bao, Qingsong Yin, Chunrui Li, Sorab Jehangir Shavaksha, H. Miles Prince, Zhen Cai, SHAN GAO, Qian Wang, Di Wang, YI LI, Mingfei Zhang, Qiumei Deng, Qiaoyang Lu, Chengjun Jiang, Fang Ren, Danqing Wu, Shuqi Zeng, Yonghong Zhu, Yi Tao, Yuanfang Liu, Jian-Qing Mi
Journal: Blood
Blood (2024) 144 (Supplement 1): 498.
https://doi.org/10.1182/blood-2024-193738
Published: 2024
Journal Articles

Flumatinib with Low-Intensity Chemotherapy in Elderly Patients with Newly Diagnosed BCR::ABL1-Positive Acute Lymphoblastic Leukemia

Weiyang Liu, Yuanfang Liu, Yongmei Zhu, Xiangqin Weng, Cheng Wang, Wanyan Ouyang, Jie Xu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2024) 144 (Supplement 1): 5883.
https://doi.org/10.1182/blood-2024-210222
Published: 2024
Journal Articles

A Hiplot-Based Web Application for the Rapid Prediction of Adult BCR::ABL1 -Positive and BCR::ABL1 -like B-Cell Precursor Acute Lymphoblastic Leukemia

Jianfeng Li, Yuchen Yan, Cheng Wang, Weiyang Liu, Han Yan, Lingling Zhao, Xiangqin Weng, Yongmei Zhu, Jiayi Ren, Lijun Peng, Jiaojiao Zhang, Yuanfang Liu, Weiping Zhang, Jie Xu, Duohui Jing, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 5926.
https://doi.org/10.1182/blood-2024-210369
Published: 2024
Journal Articles

Low-Risk Group Identified By a Refined Prognostic System Integrating Both IKZF1 plus genotyping and MRD Assessment in Adult BCR::ABL1 -Positive Acute Lymphoblastic Leukemia

Cheng Wang, Jianfeng Li, Weiyang Liu, Han Yan, Yuchen Yan, Lingling Zhao, Jiayi Ren, Lijun Peng, Jiaojiao Zhang, Yuanfang Liu, Xiangqin Weng, Yongmei Zhu, Weiping Zhang, Jie Xu, Duohui Jing, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 1457.
https://doi.org/10.1182/blood-2024-209664
Published: 2024
Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

Shanshan Suo, Wen-Juan Yu, Ying Lu, Jiejing Qian, Liping Mao, Jin Wang, Lijing Shen, Bingzong Li, Huafeng Wang, Wenyuan MAI, Wanzhuo Xie, Xiaomin Wang, Dan Zhao, Yuanfang Liu, Chuan He, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2869.
https://doi.org/10.1182/blood-2023-191190
Published: 2023
Journal Articles

A Phase II Study of Flumatinib with Chemotherapy for Newly Diagnosed BCR::ABL1-Positive Acute Lymphoblastic Leukemia in Adults: Updated Results from RJ-ALL2020.2A Trial

Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5880.
https://doi.org/10.1182/blood-2023-180326
Published: 2023
Journal Articles

Dose Escalation of Blinatumomab Is a Better Option for MRD-Positive CR Patients, Results from a Single-Center Real World Study of Blinatumomab for B-Cell Acute Lymphoblastic Leukemia in China

Sijie Tang, Jiayi Ren, Weiyang Liu, Xiangqin Weng, Yongmei Zhu, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5885.
https://doi.org/10.1182/blood-2023-189703
Published: 2023
Journal Articles

Metabolomic Insights into the Pathogenesis and Prognostic Potential of Adult Acute Lymphoblastic Leukemia

Junyu Wang, Tuantuan Gui, Tong Yin, Yuting Dai, Jing Qiao, Jianfeng Li, Jie Xu, Yuanfang Liu, Yan Wang, Yun Tan, Bo Jiao, Yongmei Zhu, Zhu Chen, Wenlian Chen, Hai Fang, Jian Hou, Jian-Qing Mi, Jin Wang, Sai-Juan Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2971.
https://doi.org/10.1182/blood-2023-184328
Published: 2023
Journal Articles

The Promising Third-Generation TKI Olverembatinib in Adult BCR::ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed/Refractory Disease

Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5902.
https://doi.org/10.1182/blood-2023-188733
Published: 2023
Journal Articles

The Prognostic Significance of 1-Year Persistent MRD Negativity in Chinese ALL Patients: 5-Year Follow-up Results from RJ-ALL 2014 Trial

Jiayi Ren, Sijie Tang, Weiyang Liu, Xiangqin Weng, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Jie Hao, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6057.
https://doi.org/10.1182/blood-2023-189710
Published: 2023
Journal Articles

A Phase II Study of Flumatinib with Chemotherapy for Newly Diagnosed Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia in Adults：Preliminary Results from RJ-ALL2020.2A Trial

Weiyang Liu, Yuanfang Liu, Yongmei Zhu, Xiangqin Weng, Cheng Wang, Wanyan Ouyang, Jie Xu, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 8981–8982.
https://doi.org/10.1182/blood-2022-165259
Published: 2022
Journal Articles

The First Report of Third-Generation TKI Olverembatinib in Adult Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed Disease

Weiyang Liu, Yuanfang Liu, Yongmei Zhu, Xiangqin Weng, Cheng Wang, Wanyan Ouyang, Jie Xu, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3266–3267.
https://doi.org/10.1182/blood-2022-166482
Published: 2022
Journal Articles

Dynamic Analysis of Cytokine Profile for Cytokine Release Syndrome in Multiple Myeloma Patients after CAR-T Cell Therapy

Shuangshuang Yang, MD, Lijuan Chen, MD PhD, Jie Xu, MD PhD, Frank Xiao-Hu Fan, MD PhD, Sun Yan, PhD, Wen Wu, MD PhD, Yan Wang, MD, Jin Wang, MD PhD, Shiwei Jin, MD, Yuebo Zhou, Yuanfang Liu, MD PhD, Yan Zhuang, PhD, Wu Zhang, PhD, Jun-Min Li, Jian Hou, PhD MD, Jian-Yong Li, MD PhD, Zhu Chen, PhD, Jian-Qing Mi, MD PhD, Sai-Juan Chen, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5617.
https://doi.org/10.1182/blood-2019-131799
Published: 2019
Journal Articles

Updated Phase 1 Results of a First-in-Human Open-Label Study of Lcar-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)

Lijuan Chen, MD PhD, Jie Xu, MD PhD, Weijun Fu, Sr., MD PhD, Shiwei Jin, MD, Shuangshuang Yang, MD, Sun Yan, PhD, Wen Wu, MD PhD, Yuanfang Liu, MD PhD, Wu Zhang, PhD, Xiangqin Weng, Yan Wang, MD, Jin WANG, MD PhD, Xiaoyi Ding, Biao Li, Jiang Zhu, MD, Zhu Chen, PhD, Frank Xiao-Hu Fan, MD PhD, Jianyong Li, MD PhD, Jian Hou, PhD MD, Sai-Juan Chen, PhD, Jian-Qing Mi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1858.
https://doi.org/10.1182/blood-2019-130008
Published: 2019
Journal Articles

Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

Jian-Qing Mi, MD PhD, Xiaohu (Frank) Fan, PhD, Jie Xu, PhDMD, Yuanfang Liu, MD PhD, Yan Zhuang, PhD, Shuangshuang Yang, Wu Zhang, PhD, Bing Chen, MD PhD, Yueying Wang, PhD, Xiangqin Weng, Junmin Li, Weijun Fu, MD, Hua Jiang, MD, Li Zhu, Zhu Chen, PhD, Sai-Juan Chen, PhD, Jian Hou, PhD MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3115.
https://doi.org/10.1182/blood.V130.Suppl_1.3115.3115
Published: 2017